Literature DB >> 7615714

Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli.

K Ramotar1, E Henderson, R Szumski, T J Louie.   

Abstract

During a 10-week period in the summer of 1990, an epidemiologic investigation of the prevalence of verotoxin (VT)-producing Escherichia coli infection was conducted in Calgary, Alberta, Canada. Consecutive stool specimens (n = 3,577) were cultured for E. coli O157:H7, and fecal filtrates were tested for free VTs (FVTs). E. coli O157:H7 was recovered from 22 specimens (0.6%), but VT was detected in 74 specimens (2.1%). Sixty-nine stool specimens positive for FVTs or E. coli O157:H7 were probed for VT genes by colony blot hybridization; 22 of 38 VT gene probe-positive isolates were non-O157:H7 E. coli organisms. Fourteen of 22 strains could not be induced to produce VT in vitro, despite the presence of FVTs in the stool sample, positivity on colony blot hybridization, positive PCR probes with the primers described by Pollard et al. (D. R. Pollard, W. M. Johnson, H. Lior, S. D. Tyler, and K. R. Rozee, J. Clin. Microbiol. 28:540-545, 1990) or Gannon et al. (V. P. Gannon, R. K. King, J. Y. Kim, and E. J. Golsteyn-Thomas, Appl. Environ. Microbiol. 58:3809-3815, 1992) (but not those described by Karch and Meyer [H. Karch and T. Meyer, J. Clin. Microbiol. 27:2751-2757, 1989]), and positive Southern blot analysis of isolates in 10 of 14 strains. The patient survey questionnaire showed that E. coli O157:H7 infection was associated with bloody diarrhea of short duration, whereas infection with other serotypes or persistence of FVT only was associated with longer-duration nonbloody diarrheal illness. We conclude that (i) detection of FVT in stools enhances the diagnosis of VT infection threefold over cultures for E. coli O157:H7, (ii) cultures for E.coli O157:H7 detect the majority of organisms of that serotype, (iii) the spectrum of disease produced by organisms of non-O157:H7 serotypes may include less severe but more protracted illness, and (iv) differences in the in vivo and in vitro expression of toxin and results of genetic probe studies highlight the need to examine control mechanisms of toxin production.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615714      PMCID: PMC228115          DOI: 10.1128/jcm.33.5.1114-1120.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study.

Authors:  C H Pai; N Ahmed; H Lior; W M Johnson; H V Sims; D E Woods
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

2.  Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features.

Authors:  C H Pai; R Gordon; H V Sims; L E Bryan
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

3.  Natural and experimental infection with an attaching and effacing strain of Escherichia coli in calves.

Authors:  R A Moxley; D H Francis
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

4.  Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus.

Authors:  S B Calderwood; J J Mekalanos
Journal:  J Bacteriol       Date:  1987-10       Impact factor: 3.490

5.  Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli.

Authors:  N A Strockbine; L R Marques; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

6.  Results of a screening method used in a 12-month stool survey for Escherichia coli O157:H7.

Authors:  A A Harris; R L Kaplan; L J Goodman; M Doyle; W Landau; J Segreti; K Mayer; S Levin
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

7.  H7 antiserum-sorbitol fermentation medium: a single tube screening medium for detecting Escherichia coli O157:H7 associated with hemorrhagic colitis.

Authors:  J J Farmer; B R Davis
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

8.  Sporadic occurrence of hemorrhagic colitis associated with Escherichia coli O157:H7 in Newfoundland.

Authors:  S Ratnam; S B March
Journal:  CMAJ       Date:  1986-01-01       Impact factor: 8.262

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.

Authors:  J G Wells; B R Davis; I K Wachsmuth; L W Riley; R S Remis; R Sokolow; G K Morris
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

View more
  16 in total

1.  An epidemiological study on Verotoxin-producing Escherichia coli (VTEC) infection among population of northern region of Iran (Mazandaran and Golestan provinces).

Authors:  Mohammad Mehdi Aslani; Saeid Bouzari
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  Importance of testing stool specimens for Shiga toxins.

Authors:  C H Park; H J Kim; D L Hixon
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

3.  Non-O157 verotoxigenic Escherichia coli and beef: a Canadian perspective.

Authors:  Alexander Gill; Colin O Gill
Journal:  Can J Vet Res       Date:  2010-07       Impact factor: 1.310

4.  Rapid Immunoassay for detection of Escherichia coli O157 directly from stool specimens.

Authors:  C H Park; N M Vandel; D L Hixon
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

5.  Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region.

Authors:  Johann D D Pitout; Daniel B Gregson; Deirdre L Church; Sameer Elsayed; Kevin B Laupland
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

6.  Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli.

Authors:  K S Kehl; P Havens; C E Behnke; D W Acheson
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

7.  Occurrence of potentially human-pathogenic Escherichia coli O103 in Norwegian sheep.

Authors:  Camilla Sekse; Marianne Sunde; Petter Hopp; Torkjel Bruheim; Kofitsyo Sewornu Cudjoe; Bjørg Kvitle; Anne Margrete Urdahl
Journal:  Appl Environ Microbiol       Date:  2013-09-27       Impact factor: 4.792

8.  Molecular characterization reveals three distinct clonal groups among clinical shiga toxin-producing Escherichia coli strains of serogroup O103.

Authors:  Atsushi Iguchi; Sunao Iyoda; Makoto Ohnishi
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

9.  Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga Toxin-producing E. coli in stool samples.

Authors:  Patrick J Gavin; Lance R Peterson; Anna C Pasquariello; Joanna Blackburn; Mark G Hamming; Kuo J Kuo; Richard B Thomson
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999.

Authors:  J E Blanco; M Blanco; M P Alonso; A Mora; G Dahbi; M A Coira; J Blanco
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.